AYA vs BGT

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

AYA

ARTRYA FPO [AYA]

54MEDIUM

BGT

BIOGENETEC FPO [BGT]

54MEDIUM

Score Breakdown

AYA BGT
Technical
79
68
Catalyst
50
51
Sentiment
50
50
Fundamental
82
41
Momentum
72
80
Risk Gate
50
34

Key Metrics

AYA Metric BGT
$478.6MMarket Cap$10.7M
451KAvg Volume (20d)128K
+0.8%Short InterestN/A
$5.24052-Week High$0.061
$0.56052-Week Low$0.016
+8.6%Daily Change+0.0%
$3.390Entry Price$0.035
-37.9%ROE-202.2%
N/AProfit MarginN/A

Active Signals

AYA Signals

MACD just crossed bullish — momentum is shifting to the upside
Watch out — volume is flowing out even as price holds up. Distribution pattern
On a tear — up 26.5% over the last 5 days
Beating the Small Ords index — relative strength of 1.11, so it's outpacing the pack
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Trading above the 200-day average — the long-term trend is on your side
Strong cash runway (15 quarters)
Very high P/S ratio (16504.5x)

BGT Signals

Stochastic is deep in oversold territory — bounce conditions forming
Beating the Small Ords index — relative strength of 1.15, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Critical cash runway (1.7 quarters)
Strong revenue growth (+208%)
Micro-cap ($5-20M) - high risk
CANSLIM S: Tight float (35%)
Not enough chatter to gauge sentiment — defaulting to neutral

Ask Scout AI to compare AYA and BGT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
AYA Full Analysis → BGT Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).